false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Individualized Care for Managing Cushing Syndrome
Individualized Care for Managing Cushing Syndrome
Individualized Care for Managing Cushing Syndrome
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This educational session on individualized care for managing Cushing's syndrome featured experts Dr. Lisa Nachtegal, Dr. Anthony Heaney, and Dr. Richard Aukus, discussing the complexities of diagnosis, pathophysiology, and treatment. Cushing’s syndrome, caused by excessive cortisol often due to pituitary (ACTH-dependent), adrenal (ACTH-independent) tumors, or ectopic ACTH secretion, remains rare but underdiagnosed. Mild autonomous cortisol secretion (MACS), a less obvious form without overt symptoms, is increasingly recognized and linked to cardiovascular and metabolic risks.<br /><br />Diagnosis involves careful clinical assessment for signs like striae, bruising, and myopathy, alongside biochemical testing including late-night salivary cortisol, 1 mg dexamethasone suppression, and 24-hour urinary free cortisol. Challenges arise with discordant clinical and biochemical presentations and rare cases with negative imaging, necessitating advanced tests like inferior petrosal sinus sampling and DDAVP stimulation.<br /><br />Treatment emphasizes surgery as the primary approach but highlights the glucocorticoid withdrawal syndrome—a difficult, expected postoperative phase requiring patient education and support. Medical therapies include dopamine agonists (cabergoline), somatostatin analogs (pasireotide), glucocorticoid receptor antagonists (mifepristone), and cortisol synthesis inhibitors (metyrapone, ketoconazole, levoketoconazole, osilodrostat) with varying efficacy and side effects.<br /><br />Conversations also addressed management issues like venous thromboembolism prophylaxis, particularly perioperatively or in severe cases, and the impact of inflammation on cortisol signaling. The session underscored the complexity and heterogeneity of Cushing's syndrome, the importance of individualized diagnosis and treatment strategies, and the need for vigilant long-term follow-up to manage comorbidities and detect recurrence.
Keywords
Cushing's syndrome
individualized care
diagnosis
pathophysiology
treatment
Mild autonomous cortisol secretion (MACS)
biochemical testing
glucocorticoid withdrawal syndrome
medical therapies
venous thromboembolism prophylaxis
long-term follow-up
×